Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New P2Y(12) inhibitors.

× No keyword cloud information.

48 in total

Review 1. P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors: Christian Gachet
Journal: Purinergic Signal Date: 2012-04-11 Impact factor: 3.765

2. Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?

Authors: Carlo Patrono; Colin Baigent
Journal: Nat Rev Cardiol Date: 2010-06 Impact factor: 32.419

Review 3. State of the art of new P2Y12 antagonists.

Authors: Marco Cattaneo; Gian Marco Podda
Journal: Intern Emerg Med Date: 2010-02-23 Impact factor: 3.397

4. Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents.

Authors: Jorge Magallon; Jianchun Chen; Leroy Rabbani; George Dangas; Jing Yang; James Bussel; Thomas Diacovo
Journal: Circulation Date: 2011-01-10 Impact factor: 29.690

Review 5. Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors: Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal: Cell Mol Life Sci Date: 2017-05-09 Impact factor: 9.261

Review 6. P2Y12 receptor: platelet thrombus formation and medical interventions.

Authors: Fatemeh Moheimani; Denise E Jackson
Journal: Int J Hematol Date: 2012-10-01 Impact factor: 2.490

7. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

Authors: Shir Yelovitch; Haim M Barr; Jean Camden; Gary A Weisman; Ela Shai; David Varon; Bilha Fischer
Journal: J Med Chem Date: 2012-08-20 Impact factor: 7.446

Review 8. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors: Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal: Purinergic Signal Date: 2013-02-13 Impact factor: 3.765

Review 9. A transition of P2Y12 antagonists for acute coronary syndrome: benefits, risks and costs.

Authors: Wei Eric Wang; Hongyong Wang; Xukai Wang; Chunyu Zeng
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

10. Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12.

Authors: Y Zhang; J Ye; L Hu; S Zhang; S H Zhang; Y Li; S P Kunapuli; Z Ding
Journal: J Thromb Haemost Date: 2012-10 Impact factor: 5.824